Biotech Stocks: Amarin, AMAG rally, but drug indexes fall
Amarin Corp. and AMAG Pharmaceuticals shares are rallying in recent trading as the drug sector’s two key indexes fall.
Read more on Market Watch
Biotech Stocks: Merck, drug indexes drift south
Merck & Co. shares are trading lower early Tuesday following news that it has appointed its president, Kenneth Frazier, to succeed retiring CEO Richard Clark.
Read more on Market Watch
Orexigen soars on Takeda deal; drug indexes slip
BOSTON (MarketWatch) — Orexigen Therapeutics was in the spotlight early Thursday as shares of the biotech group soared on news that Japanese pharmaceutical giant Takeda Pharmaceutical Co. has agreed to commercialize Orexigen’s new diet drug Contrave in North America, if and when it receives regulatory approval. Orexigen expects to receive a decision from the U.S. Food and Drug Administration on …
Read more on Market Watch
Powered by Yahoo! Answers
